Advanced Hemostatic Systems for Enhanced Bleeding Control

The invention integrates anion exchanger-based hemostatic compositions with cutting-edge technologies like AI, IoT, blockchain, and nanomaterials to create a new generation of hemostatic systems with improved efficacy, real-time monitoring, and enhanced delivery.

The original patent disclosed hemostatic compositions comprising an anion exchanger and calcium salt. However, these compositions had limitations in terms of real-time monitoring, controlled release, and bleeding risk prediction. The new inventive concept addresses these limitations by combining the patented composition with distinct technologies to create a more powerful and efficient system.

The inventive concept comprises a wearable device with a sensor for detecting bleeding and a dispenser for administering the hemostatic composition. The system utilizes machine learning algorithms to predict bleeding risk and optimize composition delivery. Additionally, the composition can be enhanced with nanomaterials for controlled release and improved efficacy. The system can be integrated with a blockchain-based tracking system for secure monitoring and data management.

The new claims introduce the synergistic combination of anion exchanger-based hemostatic compositions with AI, IoT, blockchain, and nanomaterials, which provides a new and non-obvious solution for bleeding control. The integration of these technologies enables real-time monitoring, controlled release, and bleeding risk prediction, making the system more effective and efficient than the original patent.

Alternative embodiments of the inventive concept could include the use of different AI algorithms, various IoT sensors, or distinct nanomaterials. The system could also be adapted for use in different medical settings, such as emergency response or surgical procedures.

The inventive concept has significant commercial potential in the medical device and pharmaceutical industries, particularly in the areas of emergency response, surgical hemostasis, and wound care. The system's ability to provide real-time monitoring and controlled release could revolutionize the field of bleeding control, offering a new standard of care for patients.